Immune Interactions in Severe Asthma
NCT02566668 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115
Last updated 2025-01-09
Summary
This research study is being done to learn more about severe asthma by comparing people with severe asthma to those with milder forms of asthma and people without asthma, at baseline and over time. Individuals are being asked to join a research study to help understand the differences in the lungs and blood of participants with severe asthma compared to those with milder asthma and healthy individuals, as well as differences in overall health. Investigators also want to determine whether these differences predict asthma-related and biologic outcomes over 1 year of follow up.
Conditions
Interventions
- OTHER
-
1 year Observational Follow-up
Approximately 12 months after research bronchoscopy, subjects will return for follow-up visit.
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Sally E Wenzel, MD · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2022-09-22
- Completion
- 2024-08-22
Countries
- United States
Study Locations
More Related Trials
-
Presenteeism in Severe Asthma Treated by Biotherapyasthma
NCT04463589 ·Status: COMPLETED
-
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 ·Status: COMPLETED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING
-
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
NCT00721097 ·Status: TERMINATED
-
Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma
NCT05036733 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma
NCT03563521 ·Status: COMPLETED
-
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 ·Status: COMPLETED
-
Genetic Risk Factors for Severe Asthma
NCT00090740 ·Status: COMPLETED
-
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 ·Status: COMPLETED
-
Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.
NCT00339703 ·Status: COMPLETED
-
Role of T-Cells in Asthma
NCT00001408 ·Status: COMPLETED
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)
NCT01006161 ·Status: WITHDRAWN ·Phase: PHASE2
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study for Observing Severe Asthma in Patients Treated With Tezepelumab
NCT05677139 ·Status: COMPLETED
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Asthma and Intimate Partner Violence
NCT04216680 ·Status: UNKNOWN
-
The Effect of Long Term Inhaled Corticosteroids on the Risk of Cardiovascular Morbidities
NCT00959257 ·Status: COMPLETED
-
Defining the Severe Paediatric Asthma Endotype
NCT04680117 ·Status: COMPLETED ·Phase: NA
-
Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
NCT05002621 ·Status: COMPLETED
-
Steroids In Eosinophil Negative Asthma
NCT02066298 ·Status: COMPLETED ·Phase: PHASE3